sponsored
PatientsVille.com Logo

PatientsVille

Adcirca Pulmonary Arterial Hypertension Side Effects

Adcirca Pulmonary Arterial Hypertension Side Effect Reports

Home → Adcirca → Pulmonary Arterial Hypertension

The following Adcirca Pulmonary Arterial Hypertension side effect reports were submitted by healthcare professionals and consumers.

This information will help you understand how side effects, such as Pulmonary Arterial Hypertension, can occur, and what you can do about them.

A side effect could appear soon after you start Adcirca or it might take time to develop.



Pulmonary Arterial Hypertension

This Pulmonary Arterial Hypertension side effect was reported by a consumer or non-health professional from JP. A 85-year-old patient (weight:NA) experienced the following symptoms/conditions: pulmonary arterial hypertension. The patient was prescribed Adcirca (dosage: Unk), which was started on 201401. Concurrently used drugs:
  • Flolan
When starting to take Adcirca the consumer reported the following symptoms:
  • Pulmonary Arterial Hypertension
These side effects may potentially be related to Adcirca.
Pulmonary Arterial Hypertension

This Pulmonary Arterial Hypertension Adcirca side effect was reported by a consumer or non-health professional from JP on Dec 19, 2013. A Female , 42 years of age, was diagnosed with and was treated with Adcirca. The patient presented the following health conditions:
  • Pulmonary Arterial Hypertension
. Adcirca dosage: 40 Mg, Qd. Additional drugs used at the same time:
  • Florent
Pulmonary Arterial Hypertension

This is a Adcirca side effect report of a 50-year-old patient (weight:NA) from JP, suffering from the following symptoms/conditions: pulmonary arterial hypertension, who was treated with Adcirca (dosage:Unk, start time: May 24, 2013), combined with: NA., and developed a serious reaction and a Pulmonary Arterial Hypertension side effect. The patient presented with:
  • Pulmonary Arterial Hypertension
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Adcirca treatment in patients suffering from pulmonary arterial hypertension, resulting in Pulmonary Arterial Hypertension.

Pulseless Electrical Activity, Microangiopathy, Scleroderma, Pulmonary Arterial Hypertension

A 77-year-old female patient (weight: NA) from US with the following symptoms: NA started Adcirca treatment (dosage: NA) on NS. Soon after starting Adcirca treatment, the consumer experienced several side effects, including:
  • Pulseless Electrical Activity
  • Microangiopathy
  • Scleroderma
  • Pulmonary Arterial Hypertension
. Concurrently used drugs:
  • Tyvaso (9 Df, Unk)
  • Coumadin
The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Adcirca side effects, such as Pulmonary Arterial Hypertension.
Condition Aggravated, Pulmonary Arterial Hypertension, Thrombocytopenia, Presyncope

A female patient from CANADA was prescribed and started Adcirca on Jun 11, 2012. Patient felt the following Adcirca side effects: condition aggravated, pulmonary arterial hypertension, thrombocytopenia, presyncope Additional patient health information: Female , 63 years of age, weighting 111.3 lb, The consumer reported the following symptoms: . Adcirca dosage: NA. Concurrently used drugs:
  • Fragmin
  • Vitamin D
  • Clonazepam
  • Loperamide
  • Furosemide
  • Acetaminophen
  • Escitalopram Oxalate
  • Trazodone Hcl
The patient was hospitalized.
Pulmonary Arterial Hypertension, Dyspnoea

This report suggests a potential Adcirca Pulmonary Arterial Hypertension side effect(s) that can have serious consequences. A 42-year-old female patient from UNITED STATES (weight:NA) was diagnosed with the following health condition(s): NA and used Adcirca (dosage: NA) starting Aug 04, 2010. Soon after starting Adcirca the patient began experiencing various side effects, including:
  • Pulmonary Arterial Hypertension
  • Dyspnoea
Drugs used concurrently:
  • Letairis (10 Mg, Unk)
Although Adcirca demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Pulmonary Arterial Hypertension, may still occur.
Pulmonary Arterial Hypertension, Vision Blurred

An adverse event was reported by a consumer or non-health professional on Apr 05, 2012 by a Female taking Adcirca (dosage: NA) . Location: UNITED STATES , 43 years of age, patient began experiencing various side effects, including: Directly after treatment started, patient experienced the unwanted or unexpected Adcirca side effects: pulmonary arterial hypertension, vision blurred. Additional medications/treatments:
Associated medications used:
  • Letairis (10 Mg, Unk)
The patient was hospitalized.
Dizziness, Pulmonary Arterial Hypertension

This Pulmonary Arterial Hypertension problem was reported by a consumer or non-health professional from UNITED STATES. A 63-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Dec 26, 2010 a consumer started treatment with Adcirca (dosage: NA). The following drugs/medications were being taken at the same time:
  • Letairis (5 Mg, Unk)
  • Tyvaso
When commencing Adcirca, the patient experienced the following unwanted symptoms /side effects:
  • Dizziness
  • Pulmonary Arterial Hypertension
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Pulmonary Arterial Hypertension, may become evident only after a product is in use by the general population.
Pulmonary Arterial Hypertension

This is a Adcirca side effect report of a 56-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: NA and was treated with Adcirca (dosage: NA) starting Oct 06, 2010. Concurrently used drugs:
  • Letairis (10 Mg, Unk)
Soon after that, the consumer experienced the following of symptoms:
  • Pulmonary Arterial Hypertension
The patient was hospitalized. This opens a possibility that Adcirca could cause Pulmonary Arterial Hypertension and that some female patients may be more susceptible.
Pulmonary Arterial Hypertension, Interstitial Lung Disease

This Pulmonary Arterial Hypertension side effect was reported by a health professional from UNITED STATES on Nov 14, 2011. A patient from UNITED STATES , 33 years of age, weighting 220.5 lb, was treated with Adcirca. Directly after treatment started, patient experienced the unwanted or unexpected Adcirca side effects: pulmonary arterial hypertension, interstitial lung disease. Adcirca dosage: NA.
Associated medications used:
  • Tyvaso (216 Mcg (54 Mcg,4 In 1 D),inhalation)
  • Tracleer
These side effects may potentially be related to Adcirca.
Pulmonary Arterial Hypertension, Condition Aggravated

This Pulmonary Arterial Hypertension side effect was reported by a physician from UNITED STATES. A 44-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Adcirca (dosage: NA), which was started on Sep 09, 2011. Concurrently used drugs:
  • Coumadin
  • Tracleer
  • Sustiva
  • Digoxin
  • Tyvaso (18-54 Micrograms (4 In 1 D),inhalation)
  • Diuretics (diuretics)
  • Cardizem
  • Trizivir (trizivir /01505901/)
When starting to take Adcirca the consumer reported the following symptoms:
  • Pulmonary Arterial Hypertension
  • Condition Aggravated
These side effects may potentially be related to Adcirca.
Pulmonary Arterial Hypertension

This Pulmonary Arterial Hypertension Adcirca side effect was reported by a physician from UNITED STATES on Sep 12, 2011. A Female , 42 years of age, weighting 125.2 lb, was treated with Adcirca. The patient presented the following health conditions:
  • Pulmonary Arterial Hypertension
. Adcirca dosage: NA. Additional drugs used at the same time:
  • Coumadin
  • Tyvaso (72 Mcg (18 Mcg, 4 In 1 D), Inhalation)
  • Tracleer
The patient was hospitalized.
Pulmonary Arterial Hypertension

This is a Adcirca side effect report of a 68-year-old patient (weight:NA) from UNITED STATES, suffering from the following symptoms/conditions: NA, who was treated with Adcirca (dosage:NA, start time: Jan 17, 2011), combined with:
  • Tyvaso (216 Mcg (54 Mcg, 4 In 1 D), Inhalation)
  • Diuretics (diuretics)
, and developed a serious reaction and a Pulmonary Arterial Hypertension side effect. The patient presented with:
  • Pulmonary Arterial Hypertension
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Adcirca treatment in patients suffering from NA, resulting in Pulmonary Arterial Hypertension.
Pulmonary Arterial Hypertension

A 81-year-old patient (weight: NA) from UNITED STATES with the following symptoms: NA started Adcirca treatment (dosage: NA) on May 24, 2011. Soon after starting Adcirca treatment, the consumer experienced several side effects, including:
  • Pulmonary Arterial Hypertension
. Concurrently used drugs:
  • Letairis
The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Adcirca side effects, such as Pulmonary Arterial Hypertension.
Treatment Noncompliance, Pulmonary Oedema, Pulmonary Arterial Hypertension

A female patient from UNITED STATES was prescribed and started Adcirca on Jun 22, 2011. After Adcirca was administered, patient encountered several Adcirca side effects: treatment noncompliance, pulmonary oedema, pulmonary arterial hypertension Additional patient health information: Female , 65 years of age, The consumer reported the following symptoms: . Adcirca dosage: NA. Concurrently used drugs:
  • Coumadin
  • Diuretics (diuretics)
  • Tyvaso (18 To 54 Microgram (4 In 1 D) Inhalatoin)
The patient was hospitalized.
Disease Progression, Pulmonary Arterial Hypertension

This report suggests a potential Adcirca Pulmonary Arterial Hypertension side effect(s) that can have serious consequences. A 68-year-old female patient from UNITED STATES (weight:NA) was diagnosed with the following health condition(s): pulmonary arterial hypertension and used Adcirca (dosage: 1 D/f, Unk) starting Feb 05, 2007. Soon after starting Adcirca the patient began experiencing various side effects, including:
  • Disease Progression
  • Pulmonary Arterial Hypertension
Drugs used concurrently:
  • Remodulin (Unk, Unk)
Although Adcirca demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Pulmonary Arterial Hypertension, may still occur.
Renal Failure Chronic, Pulmonary Arterial Hypertension

An adverse event was reported by a physician on Jan 12, 2011 by a male taking Adcirca (dosage: 40 Mg, Daily (1/d)) was diagnosed with and. Location: CANADA , 60 years of age, weighting 284.4 lb, patient began experiencing various side effects, including: Patient felt the following Adcirca side effects: renal failure chronic, pulmonary arterial hypertension. Additional medications/treatments:
Multiple prescriptions taken:
  • Bosentan (125 Mg, 2/d)
  • Allopurinol (200 Mg, Daily (1/d))
  • Crestor (40 Mg, Each Evening)
  • Zaroxolyn (10 Mg, Daily (1/d))
  • Insulin
  • Aldactazide (1 D/f, Daily (1/d))
  • Acetylsalicylic Acid (81 Mg, Daily (1/d))
  • Lasix (160 Mg, 2/d)
Pulmonary Arterial Hypertension, Renal Failure Chronic

This Pulmonary Arterial Hypertension problem was reported by a physician from CANADA. A 60-year-old patient (weight: NA) was diagnosed with the following medical condition(s): pulmonary hypertension.On NS a consumer started treatment with Adcirca (dosage: NA). The following drugs/medications were being taken at the same time: NA. When commencing Adcirca, the patient experienced the following unwanted symptoms /side effects:
  • Pulmonary Arterial Hypertension
  • Renal Failure Chronic
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as Pulmonary Arterial Hypertension, may become evident only after a product is in use by the general population.
Cardiac Failure, Pulmonary Arterial Hypertension

This is a Adcirca side effect report of a 75-year-old patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: NA and was treated with Adcirca (dosage: NA) starting NS. Concurrently used drugs: NA. Soon after that, the consumer experienced the following of symptoms:
  • Cardiac Failure
  • Pulmonary Arterial Hypertension
This opens a possibility that Adcirca could cause Pulmonary Arterial Hypertension and that some patients may be more susceptible.

DISCLAIMER: ALL DATA PROVIDED AS-IS, refer to terms of use for additional information.

Adcirca Pulmonary Arterial Hypertension Causes and Reviews


Pulmonary hypertension (PH) is high blood pressure in the arteries to your lungs. It is a serious condition. If you have it, the blood vessels that carry blood from your heart to your lungs become hard and narrow. Your heart has to work harder to pump the blood through. Over time, your heart weakens and cannot do its job and you can develop heart failure.

Symptoms of PH include

  • Shortness of breath during routine activity, such as climbing two flights of stairs
  • Tiredness
  • Chest pain
  • A racing heartbeat
  • Pain on the upper right side of the abdomen
  • Decreased appetite

As PH worsens, you may find it hard to do any physical activities.

There are two main kinds of PH. One runs in families or appears for no known reason. The other kind is related to another condition, usually heart or lung disease.

There is no cure for PH. Treatments can control symptoms. They involve treating the heart or lung disease, medicines, oxygen, and sometimes lung transplantation.

NIH: National Heart, Lung, and Blood Institute


Adcirca Pulmonary Arterial Hypertension Reviews

Sun, 15 Jan 2012

Can I take lorazepam with Adcirca?

DISCLAIMER: ALL DATA PROVIDED AS-IS, refer to terms of use for additional information.

Common Drugs

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Top Adcirca Side Effects

Death (70)
Dyspnoea (53)
Pneumonia (39)
Headache (31)
Nausea (19)
Pulmonary Arterial Hypertension (19)
Hypotension (17)
Vision Blurred (16)
Cardiac Failure Congestive (16)
Chest Pain (15)
Dizziness (15)
Vomiting (15)
Fluid Retention (14)
Back Pain (14)
Pulmonary Hypertension (14)
Diarrhoea (14)
Renal Failure (11)
Gastrointestinal Haemorrhage (11)
Hospitalisation (11)
Oedema Peripheral (11)
Syncope (11)
Oedema (10)
Pain In Extremity (10)
Respiratory Failure (10)
Visual Impairment (10)
Flushing (9)
Arthralgia (8)
Cardiac Failure (8)
Fatigue (8)
Epistaxis (7)
Off Label Use (7)
Asthenia (7)
Condition Aggravated (7)
Cough (7)
Blood Pressure Decreased (7)
Infection (7)
Interstitial Lung Disease (7)
Pain (7)
Palpitations (7)
Unevaluable Event (7)
Malaise (7)
Abdominal Pain (6)
Right Ventricular Failure (6)
Heart Rate Increased (6)
Loss Of Consciousness (6)
Insomnia (6)
Cerebrovascular Accident (6)
Atrial Fibrillation (6)
Anaemia (6)
Myalgia (6)

➢ More

Adcirca Common Side Effects

If you experienced any harmful or unwanted effects of Mucinex, please share your experience. This could help to raise awareness about Mucinex side effects, identify uknown risks and inform health professionals and patients taking Mucinex.

Examples: headache, dizziness

The most commonly reported Adcirca side effects (click to view or check a box to report):

Death (70)
Dyspnoea (53)
Pneumonia (39)
Headache (31)
Pulmonary Arterial Hypertension (19)
Nausea (19)
Hypotension (17)
Cardiac Failure Congestive (16)
Vision Blurred (16)
Dizziness (15)
Vomiting (15)
Chest Pain (15)
Pulmonary Hypertension (14)
Diarrhoea (14)
Back Pain (14)
Fluid Retention (14)
Oedema Peripheral (11)
Hospitalisation (11)
Gastrointestinal Haemorrhage (11)
Renal Failure (11)

➢ More


Don't miss out on new findings! Check the latest Clinical Research and Recruiting Clinical Trials for Your Health Condition

Check out clinical research studies for common conditions: Fatigue, Dizziness, Orajel, Viagra, Diarrhea , Controloc,, Topral, Prilocain, Meningoencephalitis, 19 FR. FULL FLUTED WITH 4.7 MM TROCAR CHANNEL DRAIN, Superficial, Toprol, TOTALLLY IMPLANTABLE PULSE GENERATOR, VASCUCLAR CLOSURE SYSTEM, Robitussin, Natazia, Velcade, Kayexalate, Quetiapin, ACONITUM, Carmustine, Nifedipine, Exocin Ofloxacin), Hydroxychloriquine, Tramadol 50 mg akyma for ultrim, Labs, Ache, Imovane, Harse, Digoxin-digitek-tabs, Blenoxane, Descutan, Orphenadrine, Paliperidone, Fungard, Aldesleukin, Dalacin S, Gluco slim, Epilim Tablets, Zavalin, Nonacog, Longastatina, Lodopin, Pentazocine And Naloxone Hydrochlorides, Xatral

Discuss Adcirca Side Effects

Notice - The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Viewing and using of this information is subject to accepting Terms Of Use. PatientsVille.com does not provide medical advice, diagnosis or treatment. The information regarding adverse reports, reviews and polls contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of side effects, adverse drug reactions or for establishing or changing of patient treatments. Thank you for visiting Patientsville.com!